Street Talk

No deal: Pacific Smiles board set to reject Genesis’ revised $311m bid

Sarah Thompson, Kanika Sood and Emma Rapaport

Nov 13, 2024 – 9.30am

Email LinkedIn Twitter Facebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Genesis Capital still can’t get an appointment to see the dentist.

Street Talk understands the board of the $310 million dental chain is set to reject Genesis’ revised “best and final” $1.95-per-share offer after two days of deliberations – $1.9825 if you include the October dividend.

Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.

Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.

Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.